Suven Pharmaceuticals Ltd Declares Final Dividend of Rs 1

Suven Pharmaceuticals Ltd Declares Final Dividend of Rs 1

The Board of Directors of Suven Pharmaceuticals Ltd (SUVENPHAR) held its meeting on June 8, 2021. It has declared Dividend of Rs 1 per equity share for the financial year 2020-21.

dividends9 telegram

 

Suven Pharmaceuticals Ltd Q4 Result

The company reported 40.27% yoy rise in consolidated net revenues for the Mar-21 quarter at Rs 259.16 cr. On a sequential basis, net sales revenues were down -5.74% compared to total revenues in the Dec-20 quarter at Rs 274.93 cr.

Similar Posts

Suven Pharmaceuticals Ltd Dividend Record Date

The company in its letter has informed the exchanges that it has fixed 17 August 2021 as the Record date. Consequently, the declared dividend will be paid to those members who hold shares in physical form or in electronic form and whose names appear in the Register of Members of the Company on Record Date.

Moreover, to receive dividend, you must have shares in your demat account on record date. Hence, you should buy shares before ex-dividend date. Note – If you buy shares on ex-dividend date, you will not be eligible to receive dividend. Bookmark our website for latest and upcoming dividend announced by companies in 2021.

dividends9 telegram

dividends9 telegram

Above all, here is the copy of statement, the company has sent to the exchanges:

With reference to the above subject, we wish to inform you that the Board of Directors of the company, at its meeting held today i.e. June 8, 2021 has recommended a final dividend of Rs. 1.00 per equity share of face value of Rs 1/- each for the year 2020-2021.

Important Dates

  • Company – Suven Pharmaceuticals Ltd
  • Script Name – SUVENPHAR (NSE) and 543064 (BSE)
  • Dividend Amount – 1 Rs Per Share
  • Dividend Type – Final
  • Ex-Dividend Date – 13 August 2021
  • Record Date – 17 August 2021
  • Payment Date – 7 September 2021

Also, you can find more information about Suven Pharmaceuticals Ltd on National Stock Exchange and Moneycontrol – Suven Pharmaceuticals Ltd. provides services to leading Global Life Science and Fine Chemical majors including Custom Synthesis, Process R&D, Scale Up and Contract Manufacturing of intermediates, APIs and formulations.

 

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *